Similar early characteristics but variable neurological outcome of patients with a de novo mutation of KCNQ2.

Archive ouverte

Milh, Mathieu | Boutry-Kryza, Nadia | Sutera-Sardo, Julie | Mignot, Cyril | Auvin, Stéphane | Lacoste, Caroline | Villeneuve, Nathalie | Roubertie, Agathe | Heron, Bénédicte | Carneiro, Maryline | Kaminska, Anna | Altuzarra, Cécilia | Blanchard, Gaëlle | Ville, Dorothée | Barthez, Marie, Anne | Heron, Delphine | Gras, Domitille | Afenjar, Alexandra | Dorison, Nathalie | Doummar, Diane | Billette de Villemeur, Thierry | An, Isabelle | Jacquette, Aurélia | Charles, Perrine | Perrier, Julie | Isidor, Bertrand | Vercueil, Laurent | Chabrol, Brigitte | Badens, Catherine | Lesca, Gaetan | Villard, Laurent

Edité par CCSD ; BioMed Central -

International audience. BACKGROUND: Early onset epileptic encephalopathies (EOEEs) are dramatic heterogeneous conditions in which aetiology, seizures and/or interictal EEG have a negative impact on neurological development. Several genes have been associated with EOEE and a molecular diagnosis workup is challenging since similar phenotypes are associated with mutations in different genes and since mutations in one given gene can be associated with very different phenotypes. Recently, de novo mutations in KCNQ2, have been found mutated in about 10% of EOEE patients. Our objective was to confirm that KCNQ2 was an important gene to include in the diagnosis workup of EOEEs and to fully describe the clinical and EEG features of mutated patients. METHODS: We have screened KCNQ2 in a cohort of 71 patients with an EOEE, without any brain structural abnormality. To be included in the cohort, patient's epilepsy should begin before three months of age and be associated with abnormal interictal EEG and neurological impairment. Brain MRI should not show any structural abnormality that could account for the epilepsy. RESULTS: Out of those 71 patients, 16 had a de novo mutation in KCNQ2 (23%). Interestingly, in the majority of the cases, the initial epileptic features of these patients were comparable to those previously described in the case of benign familial neonatal epilepsy (BFNE) also caused by KCNQ2 mutations. However, in contrast to BFNE, the interictal background EEG was altered and displayed multifocal spikes or a suppression-burst pattern. The ongoing epilepsy and development were highly variable but overall severe: 15/16 had obvious cognitive impairment, half of the patients became seizure-free, 5/16 could walk before the age of 3 and only 2/16 patient acquired the ability to speak. CONCLUSION: This study confirms that KCNQ2 is frequently mutated in neonatal onset epileptic encephalopathy. We show here that despite a relatively stereotyped beginning of the condition, the evolution is highly variable in terms of epilepsy and of cognitive evolution.

Suggestions

Du même auteur

Epileptic patients with de novo STXBP1 mutations: Key clinical features based on 24 cases

Archive ouverte | Di Meglio, Chloé | CCSD

International audience. Objective: Mutations in the syntaxin binding protein 1 gene (STXBP1) have been associated mostly with early onset epileptic encephalopathies (EOEEs) and Ohtahara syndrome , with a mutation de...

A recurrent KCNQ2 pore mutation causing early onset epileptic encephalopathy has a moderate effect on M current but alters subcellular localization of Kv7 channels

Archive ouverte | Abidi, Affef | CCSD

International audience. Mutations in the KCNQ2 gene encoding the voltage-dependent potassium M channel Kv7.2 subunit cause either benign epilepsy or early onset epileptic encephalopathy (EOEE). It has been proposed ...

Prospective Multicenter Validation of a Simple Blood Test for the Diagnosis of Glut1 Deficiency Syndrome

Archive ouverte | Mochel, Fanny | CCSD

International audience. Background and Objective GLUT1 deficiency syndrome (Glut1DS) is a treatable neurometabolic disease that causes a wide range of neurologic symptoms in children and adults. However, its diagnos...

Chargement des enrichissements...